Science
Technology and Economic Assessment Panel reports expected to be produced until 2030 in response to parties’ requests
| Id | Year | Reporting type | Decision | Issue | Request by parties to TEAP | Report to be produced |
|---|---|---|---|---|---|---|
| 0 | 2024 | Progress updates | IV/13 | Technical progress update by TEAP and its TOCs | Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects | 2024 progress report |
| 1 | 2024 | Progress updates | XI/17 | Technical progress update by TEAP and its TOCs | Decision XI/17 – Report on any important new developments on an annual basis | 2024 progress report |
| 2 | 2024 | Progress updates | XXXI/8 | Procedures relevant to nominations to the TEAP and its TOCs. | Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements | 2024 progress report |
| 3 | 2024 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2024 interim report (only upon submission of nominations) |
| 4 | 2024 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2024 final report (only upon submission of nominations) |
| 5 | 2024 | Thematic reports | IV/25 | Essential-use nominations | Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision | 2024 progress report (only upon submission of nominations) |
| 6 | 2024 | Thematic reports | XXVIII/2 | Review related to the Kigali Amendment to the Montreal Protocol | Decision XXVIII/2, paragraph 5 – Conduct a technology review four or five years before 2028 to consider a compliance deferral of two years from the freeze date of 2028 for Article 5, group 2, parties to address growth above a certain threshold in several sectors | Report on technology review |
| 7 | 2024 | Thematic reports | XXXV/7 | HFC-23 emissions | Decision XXXV/7, paragraph 2 – Prepare a report for the 36th MOP containing information regarding; (a) The quantity of HFC-23 being consumed, by country and by sector; (b) Provide updated estimates on the amounts of HFC-23 generated at and emissions from HCFC-22 production facilities including methodology with respect to such emissions. In preparing this information, the Technology and Economic Assessment Panel should take into account information reported under paragraph 3 ter of Article 7 by all parties that manufacture Annex C, Group I and/or Annex F substances as well as information from other sources | Report on HFC-23 emissions |
| 8 | 2024 | Thematic reports | XXXV/8 | Feedstock uses | Decision XXXV/8 – Provide, in cooperation with the SAP as appropriate, an update on the emissions from feedstock production, as by-product and from feedstock use of controlled substances including the following: (a) Sources of such emissions, including percentage increases with respect to increased production of controlled substances to be used for feedstock applications; (b) A comparison of estimates of annual global emissions of controlled substances by species based on bottom-up calculations and estimates made by the Scientific Assessment Panel on the basis of atmospheric observations; (c) Methodology adopted for estimating the emissions; (d) Updated information on alternatives, including information on technical feasibility, economic viability, safety and sustainability; (e) Information on best practices and technologies for minimizing emissions. | 2024 progress report |
| 9 | 2024 | Thematic reports | XXXV/9 | Carbon tetrachloride emissions | Decision XXXV/9 – Provide, in consultation with the SAP, an update on the emissions of carbon tetrachloride including the following: (a) Emissions by source categories, including emissions as a percentage of total production of carbon tetrachloride with a description of the methodology used by the Panel; (b) Updated information on alternatives for carbon tetrachloride use as feedstock applications including information on technical feasibility, economic viability, safety, and sustainability; (c) Updated information on best practices and technologies, for minimising carbon tetrachloride emissions. | 2024 progress report |
| 10 | 2024 | Thematic reports | XXXV/10 | Energy efficiency | Decision XXXV/10 – Provide updates on the information identified in paragraph 1 (a) of Decision XXXIV/3, taking into account discussions at the 35th MOP. | 2024 progress report |
| 11 | 2024 | Thematic reports | XXXV/6 | Very short-lived substances | Decision XXXV/6 – Provide, in cooperation with SAP, for consideration by the 46th OEWG: (a) updated information on very short-lived substances, including their ozone-depleting potential and the impact of each of the very short-lived substances on the stratospheric ozone layer in quantifiable terms, (b) Information on alternatives to very short-lived substances in the main applications for which they are currently used, including on availability, technical feasibility, economic viability, safety and sustainability. | 2024 progress report |
| 12 | 2024 | Thematic reports | XXXV/11 | Life-cycle refrigerant management | Decision XXXV/11, paragraph 1 –Prepare a report to be presented at the 46th OEWG on: (a) Available technologies for the leakage prevention, recovery, recycling, reclamation and destruction of refrigerants, and their accessibility in parties operating under paragraph 1 of Article 5 of the Montreal Protocol, including regionally specific approaches; (b)The obstacles and challenges associated with the effective leakage prevention, recovery, recycling, reclamation and destruction of refrigerants; (c)The costs and climate and ozone benefits associated with the leakage prevention, recovery, recycling, reclamation and disposal of refrigerants, taking into account the experience under the Multilateral Fund for the Implementation of the Montreal Protocol; (d) Policies, incentive schemes, such as producer’s responsibility schemes, good practices and lessons learned related to ensuring the effective leakage prevention, recovery, recycling, reclamation and disposal of refrigerants. | Report on Life-cycle refrigerant management |
| 13 | 2024 | Thematic reports | XXXI/5 | Laboratory and analytical uses | Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report | 2024 progress report (only if new compelling information becomes available) |
| 14 | 2024 | Thematic reports | XXXI/6 | Process agents | Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report | 2024 progress report (only if new compelling information becomes available) |
| 15 | 2024 | Thematic reports | XXX/15 | Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances | Review only if the specific conditions set out in decision XXX/15 are met | |
| 16 | 2025 | Progress updates | IV/13 | Technical progress update by TEAP and its TOCs | Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects | 2025 progress report |
| 17 | 2025 | Progress updates | XI/17 | Technical progress update by TEAP and its TOCs | Decision XI/17 – Report on any important new developments on an annual basis | 2025 progress report |
| 18 | 2025 | Progress updates | XXXI/8 | Procedures relevant to nominations to the TEAP and its TOCs. | Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements | 2025 progress report |
| 19 | 2025 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2025 interim report (only upon submission of nominations) |
| 20 | 2025 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2025 final report (only upon submission of nominations) |
| 21 | 2025 | Thematic reports | IV/25 | Essential-use nominations | Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision | 2025 progress report (only upon submission of nominations) |
| 22 | 2025 | Thematic reports | XXXI/5 | Laboratory and analytical uses | Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report | 2025 progress report (only if new compelling information becomes available) |
| 23 | 2025 | Thematic reports | XXXI/6 | Process agents | Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report | 2025 progress report (only if new compelling information becomes available) |
| 24 | 2025 | Thematic reports | XXX/15 | Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances | Review only if the specific conditions set out in decision XXX/15 are met | |
| 25 | 2026 | Progress updates | IV/13 | Technical progress update by TEAP and its TOCs | Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects | 2026 progress report |
| 26 | 2026 | Progress updates | XI/17 | Technical progress update by TEAP and its TOCs | Decision XI/17 – Report on any important new developments on an annual basis | 2026 progress report |
| 27 | 2026 | Progress updates | XXXI/8 | Procedures relevant to nominations to the TEAP and its TOCs. | Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements | 2026 progress report |
| 28 | 2026 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2026 interim report (only upon submission of nominations) |
| 29 | 2026 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2026 final report (only upon submission of nominations) |
| 30 | 2026 | Thematic reports | IV/25 | Essential-use nominations | Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision | 2026 progress report (only upon submission of nominations) |
| 31 | 2026 | Thematic reports | XXXI/5 | Laboratory and analytical uses | Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report | TEAP 2026 quadrennial assessment report |
| 32 | 2026 | Thematic reports | XXXI/6 | Process agents | Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report | TEAP 2026 quadrennial assessment reports |
| 33 | 2026 | Thematic reports | XXX/15 | Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances | Review only if the specific conditions set out in decision XXX/15 are met | |
| 34 | 2026 | Periodic assessments | Replenishment study for 2027–2029 | Expected decision at the 37th MOP, in 2025, and potential additional guidance by OEWG (48th meeting) in 2026 – Prepare a report on the appropriate level of the 2027–2029 replenishment of the Multilateral Fund | Replenishment task force report (2027–2029) | |
| 35 | 2026 | Periodic assessments | Replenishment study for 2027–2029 | Expected decision at the 37th MOP, in 2025, and potential additional guidance by OEWG (48th meeting) in 2026 – Prepare a report on the appropriate level of the 2027–2029 replenishment of the Multilateral Fund | Supplement to the replenishment task force report | |
| 36 | 2026 | Periodic assessments | XXXV/3 | Quadrennial assessment | Decision XXX/3 - Prepare the TEAP 2026 quadrennial assessment | TEAP and TOCs 2026 quadrennial assessment reports (6) |
| 37 | 2026 | Periodic assessments | XXIX/12 | HFCs not listed in Annex F of the Montreal Protocol | Decision XXIX/12 – Provide in the quadrennial reports of the assessment panels to be presented to the 35th MOP, in 2023, and every four years thereafter, information on the consumption and production of HFCs not listed in Annex F of the Protocol that have global warming potential no less than the lowest global warming potential of the HFCs listed in Annex F | TEAP and TOCs 2026 quadrennial assessment reports (6) |
| 38 | 2026 | Periodic assessments | XXX/2 | HCFC availability | Decision XXX/2 – Provide in its quadrennial reports to be presented to the 35th MOP, in 2023, and to the 39th MOP, in 2027, information on the availability of Annex C, group I, substances, including amounts available from recovery, recycling and reclamation, and best available information on country-level and total known stocks, as well as the availability of alternative options for the applications described in Article 2F, paragraphs 6 (a) and 6 (b) | TEAP and TOCs 2026 quadrennial assessment reports (6) |
| 39 | 2027 | Progress updates | IV/13 | Technical progress update by TEAP and its TOCs | Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects | 2027 progress report |
| 40 | 2027 | Progress updates | XI/17 | Technical progress update by TEAP and its TOCs | Decision XI/17 – Report on any important new developments on an annual basis | 2027 progress report |
| 41 | 2027 | Progress updates | XXXI/8 | Procedures relevant to nominations to the TEAP and its TOCs. | Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements | 2027 progress report |
| 42 | 2027 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2027 interim report (only upon submission of nominations) |
| 43 | 2027 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2027 final report (only upon submission of nominations) |
| 44 | 2027 | Thematic reports | IV/25 | Essential-use nominations | Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision | 2027 progress report (only upon submission of nominations) |
| 45 | 2027 | Thematic reports | XXXI/5 | Laboratory and analytical uses | Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report | 2027 progress report (only if new compelling information becomes available) |
| 46 | 2027 | Thematic reports | XXXI/6 | Process agents | Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report | 2027 progress report (only if new compelling information becomes available) |
| 47 | 2027 | Thematic reports | XXX/15 | Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances | Review only if the specific conditions set out in decision XXX/15 are met | |
| 48 | 2027 | Periodic assessments | XXXV/3 | Quadrennial assessment | Decision XXXV/3 - Prepare the assessment panels’ synthesis report | 2026 quadrennial assessment synthesis report |
| 49 | 2027 | Periodic assessments | XXVIII/2 | Review related to the Kigali Amendment to the Montreal Protocol | Decision XXVIII/2, paragraph 4 – Conduct periodic reviews of alternatives to HFCs in 2022 and every five years thereafter, and provide technological and economic assessments of the latest available and emerging alternatives to HFCs (second review) | Report on review of alternatives to HFCs |
| 50 | 2028 | Progress updates | IV/13 | Technical progress update by TEAP and its TOCs | Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects | 2028 progress report |
| 51 | 2028 | Progress updates | XI/17 | Technical progress update by TEAP and its TOCs | Decision XI/17 – Report on any important new developments on an annual basis | 2028 progress report |
| 52 | 2028 | Progress updates | XXXI/8 | Procedures relevant to nominations to the TEAP and its TOCs. | Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements | 2028 progress report |
| 53 | 2028 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2028 interim report (only upon submission of nominations) |
| 54 | 2028 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2028 final report (only upon submission of nominations) |
| 55 | 2028 | Thematic reports | IV/25 | Essential-use nominations | Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision | 2028 progress report (only upon submission of nominations) |
| 56 | 2028 | Thematic reports | XXXI/5 | Laboratory and analytical uses | Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report | 2028 progress report (only if new compelling information becomes available) |
| 57 | 2028 | Thematic reports | XXXI/6 | Process agents | Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report | 2028 progress report (only if new compelling information becomes available) |
| 58 | 2028 | Thematic reports | XXX/15 | Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances | Review only if the specific conditions set out in decision XXX/15 are met | |
| 59 | 2028 | Periodic assessments | XXVIII/2 | Review related to the Kigali Amendment to the Montreal Protocol | Decision XXVIII/2, paragraphs 32 and 33 – Periodically assess the suitability of HFC alternatives for use at high ambient temperatures, starting four years from the HFC freeze date and every four years thereafter (first review) | Assessment of high-ambient-temperature HFC alternatives |
| 60 | 2029 | Progress updates | IV/13 | Technical progress update by TEAP and its TOCs | Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects | 2029 progress report |
| 61 | 2029 | Progress updates | XI/17 | Technical progress update by TEAP and its TOCs | Decision XI/17 – Report on any important new developments on an annual basis | 2029 progress report |
| 62 | 2029 | Progress updates | XXXI/8 | Procedures relevant to nominations to the TEAP and its TOCs. | Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements | 2029 progress report |
| 63 | 2029 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2029 interim report (only upon submission of nominations) |
| 64 | 2029 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2029 final report (only upon submission of nominations) |
| 65 | 2029 | Thematic reports | IV/25 | Essential-use nominations | Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision | 2029 progress report (only upon submission of nominations) |
| 66 | 2029 | Thematic reports | XXXI/5 | Laboratory and analytical uses | Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report | 2029 progress report (only if new compelling information becomes available) |
| 67 | 2029 | Thematic reports | XXXI/6 | Process agents | Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report | 2029 progress report (only if new compelling information becomes available) |
| 68 | 2029 | Thematic reports | XXX/15 | Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances | Review only if the specific conditions set out in decision XXX/15 are met | |
| 69 | 2029 | Periodic assessments | Replenishment study for 2030–2032 | Expected decision at the 40th MOP, in 2028, and potential additional guidance by OEWG (51st meeting) in 2029 – Prepare a report on the appropriate level of the 2030–2032 replenishment of the Multilateral Fund | Replenishment task force report (2030–2032) | |
| 70 | 2029 | Periodic assessments | Replenishment study for 2030–2032 | Expected decision at the 40th MOP, in 2028, and potential additional guidance by OEWG (51st meeting) in 2029 – Prepare a report on the appropriate level of the 2030–2032 replenishment of the Multilateral Fund | Supplement to the replenishment task force report | |
| 71 | 2030 | Progress updates | IV/13 | Technical progress update by TEAP and its TOCs | Decision IV/13 – Report annually to OEWG on technical progress in reducing the use and emissions of controlled substances and assess the use of alternatives, particularly their direct and indirect global-warming effects | 2030 progress report |
| 72 | 2030 | Progress updates | XI/17 | Technical progress update by TEAP and its TOCs | Decision XI/17 – Report on any important new developments on an annual basis | 2030 progress report |
| 73 | 2030 | Progress updates | XXXI/8 | Procedures relevant to nominations to the TEAP and its TOCs. | Decision XXXI/8 – Provide, as part of its annual progress report, a summary outlining the procedures that the Panel and its technical options committees have undertaken to ensure adherence to the Panel’s terms of reference through clear and transparent procedures, including full consultations with the focal points, in line with the terms of reference, regarding: (a) nomination processes, taking into account the matrix of needed expertise and already available expertise; (b) proposed nominations and appointment decisions; (c) termination of appointments; and (d) replacements | 2030 progress report |
| 74 | 2030 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2030 interim report (only upon submission of nominations) |
| 75 | 2030 | Thematic reports | IX/6 | Critical-use nominations | Decision IX/6 – Review nominations for critical-use exemption of methyl bromide and make recommendations based on the criteria established in the decision (and other relevant decisions) | 2030 final report (only upon submission of nominations) |
| 76 | 2030 | Thematic reports | IV/25 | Essential-use nominations | Decision IV/25 – Review any submitted nominations and make recommendations in accordance with the criteria established in the decision | 2030 progress report (only upon submission of nominations) |
| 77 | 2030 | Thematic reports | XXXI/5 | Laboratory and analytical uses | Decision XXXI/5 – Report in the TEAP quadrennial report on any progress made by parties in reducing their production and consumption of ozone depleting substances for laboratory and analytical uses, on any new alternatives to those uses, and on laboratory standards that can be performed without such substances, on the understanding that, should new compelling information become available, including opportunities for significant reductions in production and consumption, that information should be reported in its annual progress report | TEAP 2030 quadrennial assessment report |
| 78 | 2030 | Thematic reports | XXXI/6 | Process agents | Decision XXXI/6 – Report in the TEAP quadrennial reports on any progress made by parties in reducing their use and emissions of controlled substances as process agents and on any new alternatives to such uses, including new production processes and emissions-reduction techniques, on the understanding that should new compelling information become available, that information should be reported in its annual progress report | TEAP 2030 quadrennial assessment report |
| 79 | 2030 | Thematic reports | XXX/15 | Process agents; destruction technologies; laboratory and analytical uses; n-propyl bromide; possible new substances | Review only if the specific conditions set out in decision XXX/15 are met | |
| 80 | 2030 | Periodic assessments | Quadrennial assessment | Expected decision at the 39th MOP, in 2027 - Prepare the TEAP 2030 quadrennial assessment | TEAP and TOCs 2030 quadrennial assessment reports (6) | |
| 81 | 2030 | Periodic assessments | XXIX/12 | HFCs not listed in Annex F of the Montreal Protocol | Decision XXIX/12 – Provide in the quadrennial reports of the assessment panels to be presented to the 35th MOP, in 2023, and every four years thereafter, information on the consumption and production of HFCs not listed in Annex F of the Protocol that have global warming potential no less than the lowest global warming potential of the HFCs listed in Annex F | TEAP and TOCs 2030 quadrennial assessment reports (6) |
1 In case the review in response to decision XXVIII/2, para. 5, is conducted four years before 2028.
2 The provisions of decision XXX/15 regarding process agents and laboratory and analytical uses are superceded by decisions XXXI/6 and XXXI/5, respectively. The process of dealing with possible new substances is set out in decision IX/24.
3 Reports to be produced on the listed issues are not indicated herein given that the time at which the respective conditions set out in decision XXX/15 will be met is not known.